Strategic performance report underscores Global Fund successes but challenges remain for service delivery and coverage of key populations

15 Nov 2018
New report combining KPI and Strategy reporting is presented to the Board

The Global Fund has achieved its targets in resource mobilization (i.e. Fifth Replenishment) and in aligning its investments with country needs and national strategic plans.

This information is contained in a report on Strategic Performance Reporting prepared for the Board’s 40th meeting just completed in Geneva on 14-15 November.


Aidspan finds gaps in the Global Fund’s response to HIV/AIDS epidemic in children

16 Dec 2015

According to a new report, children may still not be prioritized under the new funding model.


Global Fund Reports Significant Progress on ART and PMTCT

9 Apr 2013
However, low antenatal care hampering further advances

Significant progress has been achieved in providing antiretroviral therapy (ART) and preventing mother-to-child transmission of HIV (PMTCT), but low antenatal care coverage and other health systems and gender-related challenges are hampering further progress on these fronts.


A Message of Optimism and Confidence in the Future

25 Jul 2011

This article contains the text of an address by Jaqueline Lima at the opening plenary of the Global Fund 4th Partnership Forum held in São Paulo, Brazil on 28-30 June 2011. Jaqueline, a young Brazilian, shares her story as an HIV-positive mother who gave birth to a HIV-negative boy. The address was given in Portuguese; this text is a translation.


Global Fund Launches "Born HIV Free" Campaign to Rally Public and Donor Support

14 Jun 2010

The Global Fund is hoping that its Born HIV Free campaign will not only mobilise public support for a world where no child is born with HIV, but will also persuade donor countries to give more to the Fund at the Third Replenishment meeting in New York on 4-5 October 2010.


Opportunity to Reprogramme Grants to Improve PMTCT Treatment

16 Apr 2010

The Global Fund Secretariat is working with 20 countries in sub-Saharan Africa to assess the possibility of reprogramming existing Global Fund grants to allow for a switch from the use of single dose nevirapine to more effective dual or triple ARV therapy for the prevention of mother-to-child transmission (PMTCT).